HydroWhirl S tank cleaning nozzle now ATEX certified
For use in atmospheres that are potentially explosive
The HydroWhirl is designed to meet the exacting standards for effective cleaning-in-place (CIP) required in the pharmaceutical, chemical, food, dairy and beverage industries. As well as being certified for use in potentially explosive areas, the ATEX certified nozzles also meet the requirements for gas and dust approvals for all zones (0,1 and 2).
HydroWhirl nozzles are self-cleaning and self-lubricating, which eliminates the possibility of process contamination, while its compact design allows it to be fitted through small, restricted access flanges. They are ideal for medium tanks (up to 5 metres in diameter), used in the pharmaceutical and chemical, food and petrochemical industries, where superior cleaning combined with reduced cycle times, lower water, energy and chemical consumption are increasingly becoming important considerations.
You may also like
Trending Articles
You may also like
Manufacturing
Pharmaceutical labelling in focus at Interpack 2026
Well prepared for new requirements. The upcoming reform of EU pharmaceutical legislation is expected to bring stricter requirements for traceability and labelling. The new 152E HC wrap-around labelling machine, developed specifically for contract packers, covers a wide product range with minimal change parts. Also on display: specialised labelling machines for automated product handling of small batches and high-speed labelling applications.
Manufacturing
Virica Biotech and FUJIFILM Biosciences collaborate to boost AAV vector yields in HEK293 manufacturing system
Virica Biotech has announced a collaboration with FUJIFILM Biosciences to co-develop an off-the-shelf enhancer-media solution combining Virica's VSE technology with FUJIFILM's BalanCD HEK293 system, targeting improved AAV productivity and process robustness for gene therapy manufacturers
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Accelerating the development of bispecific antibodies
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains how the use of comprehensive tailored approaches can enhance bispecific antibody productivity, stability and quality while accelerating their delivery to market